Daily Market Updates: Merck and Moderna's Cancer Vaccine Worked,Who Gets Paid?

Earnings

Home›Earnings›Results›Merck and Moderna's Cancer Vaccine Worked,Who Gets Pai…

Merck and Moderna's Cancer Vaccine Worked,Who Gets Paid?

Reported · Written up by our desk · Results

Merck and Moderna's melanoma vaccine cut recurrence risk 42% in a Phase 3 trial, but results fell short of hopes, sending Moderna shares down sharply while Merck stock barely moved.

← Newer storyLockheed Martin's F-35 Deal Could Change How Wall Street Values the S…Older story →China Steps In to Rescue Stocks, But the Market Continues to Fall

More like this

EarningsWhirlpool's Stock Collapse Raises a Bigger Question About Its Recovery Potential

EarningsBoeing stock sinks 9% as company says it won't significantly ramp up 737 Max production until late 2027

EarningsAnalysts Turn Bullish on Meta Platforms Despite Post-Earnings Fall

EarningsApproaching Earnings Season, Are Pure Play Quantum Stocks Still a Good Bet?

EarningsLockheed Martin's F-35 Deal Could Change How Wall Street Values the Stock

Sources

MarketBeat RatingsMerck and Moderna's Cancer Vaccine Worked,Who Gets Paid?

Earnings

Merck and Moderna's Cancer Vaccine Worked,Who Gets Paid?

More like this

Sources

Get the close, explained.